Stock Market News3 months AbbVie’s Ovarian Cancer Drug Elahere Gets Approval in Europe Zacks
The European Commission approves ABBV’s Elahere for the treatment of platinum-resistant ovarian cancer.
XThe European Commission approves ABBV’s Elahere for the treatment of platinum-resistant ovarian cancer.
X